ArticleBMC clinical pathology2018

BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score.

Mark D Zarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.